Recruiting
A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.
NCT07203404
- Conditions
- ANCA Associated Vasculitis, ANCA-Associated Glomerulonephritis, Anti-GBM Disease, +27 more
- Locations
-
- Bioheng Study site Shanghai, China